|
|
Last Modified: 12/28/2006  First Published: 11/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
21-65
|
|
|
|
Other
|
|
|
|
LSU-97447 NCI-V97-1341, NCT00003086
|
|
|
|
|
|
|
|
Last Modified: 9/11/2008  First Published: 5/21/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
MAYO-MC0585 MAYO-IRB-1586-05, MC0585, NCT00478075
|
|
|
|
|
|
|
|
Last Modified: 11/12/2007  First Published: 5/23/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MAYO-MC048B MAYO-IRB-261-05, MC048B, NCT00482378
|
|
|
|
|
|
|
|
Last Modified: 5/5/2008  First Published: 1/14/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
MAYO-MC9981 MC9981, NCT00602706
|
|
|
|
|
|
|
|
Last Modified: 6/1/1998  First Published: 10/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
CYTOGEN-424Sm17 NCI-V97-1255
|
|
|
|
|
|
|
|
Last Modified: 12/15/2008  First Published: 10/21/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
13 to 50
|
|
|
|
NCI
|
|
|
|
JHOC-J0347 JHOC-03090802, NCT00245011
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
over 5 to 25
|
|
|
|
NCI
|
|
|
|
NCI-95-C-0113A
|
|
|
|
|
|
|
|
Last Modified: 12/3/2007  First Published: 4/14/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
ONCOTHER-20051780 ONCOTHER-424Sm35, CYTOGEN-ONCOTHER-20051780, NCT00316940
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 to 80
|
|
|
|
Other
|
|
|
|
J0467 04-09-03-03, NCT00559429
|
|
|
|